The Generative AI Use-Case Assessment for Life Sciences, 2025 from Gartner® offers a comprehensive framework for evaluating GenAI opportunities across the enterprise. CIOs can use this report to start strategic conversations to guide investment decisions in this technology.

 

We believe Axtria supports  this journey with deep domain expertise and a proven track record in life sciences transformation. We continue to deliver successful GenAI use cases for top life sciences companies, turning the insights in this report into real-world results.

 

Axtria’s Key Takeaways for CIOs:

  • Understand the prioritization of GenAI use cases by value and feasibility according to Gartner
  • Identify high-impact areas for early adoption
  • Align internal capabilities with industry benchmarks
  • Accelerate strategic planning with Axtria’s support

Download the Gartner report and begin mapping your GenAI journey with confidence.

 

Gartner, Generative AI Use-Case Assessment for Life Sciences, By Reuben Harwood, Jeff Smith et al., 12 August 2025. GARTNER is a registered trademark and service mark of Gartner, Inc. and/or its affiliates in the U.S. and internationally and is used herein with permission. All rights reserved.